Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Inverness introduces new rapid test for diagnosing chlamydia

Inverness Medical Innovations : 23 January, 2008  (New Product)
Inverness Medical has introduced the Clearview Chlamydia MF test for the rapid testing and swift diagnosis of Chlamydia trachomatis infection.
Estimates indicate that there are 92 million Chlamydia infections a year (Ref 1), making it the most common sexually transmitted disease worldwide.

Although treatable, the challenge in diagnosing chlamydia is often the lack of symptoms. With as many as a quarter of patients never returning for their results and treatment (Ref 2), Clearview Chlamydia MF ensures diagnosis and treatment can be made in a single patient visit, reducing patient anxiety and the spread of infection.

Giving rapid results in as little as 30 minutes, Clearview Chlamydia MF is suitable for both men and women by detecting Chlamydia trachomatis antigen using either female endocervical swabs or male urine samples. The easy-to-use lateral flow test has in-built procedural controls which reliably confirm the test has worked correctly. The test uses a heating step in the testing process which gives Clearview Chlamydia MF its high sensitivity, meaning clinicians can be confident in the test results.

Early treatment of chlamydia is essential in preventing the development of future complications. In women, if left untreated chlamydia can cause infertility and an increased risk of ectopic pregnancies. In men the infection can cause arthritis, as well as damage to sperm. With Clearview Chlamydia MF, Inverness Medical offers a practical answer to improving patient care and reducing the rise in this easily treatable infection.

Ref 1 - World Health Organisation.

Ref 2 - Hook, Edward W II, MD, et al. Use of Cell Culture and Rapid Diagnostic Assay for Chlamydia.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo